acne

acne

Currently available topical acne treatments have limited efficacy or strong side effects. Complex combination treatment regimens required to target different aspects of acne pathophysiology lead to poor adherence, which undermines treatment success.

DB-007-4 is a new type of drug that significantly reduces the formation of acne by shutting down inflammation and eliminating pathogenic C. acnes bacteria. DB-007-4 is well-tolerated by skin.